Clinical Trials - Phase II
Filter News
Found 29,653 articles
-
Columbia Laboratories, Inc. To Initiate A Phase 2 Clinical Trial For COL-1077, Lidocaine Bioadhesive 10% Gel, In The Second Quarter Of 2015
2/26/2015
-
ISA Pharmaceuticals Announces Start Of First Phase 1/2 Clinical Trial Of Its SLP®-AMPLIVANT® Conjugates
2/26/2015
-
Progenics Pharmaceuticals, Inc. Presents Positive Phase 2 Data For PSMA ADC In Metastatic Castration-Resistant Prostate Cancer
2/26/2015
-
Aduro Biotech Collaborates With Leaders In Cancer Research On Investigator-Sponsored Phase 2 Trial Combining Aduro’s Innovative Immunotherapies With Anti-PD-1 Technology To Treat Patients With Advanced Pancreatic Cancer
2/26/2015
-
Sangamo BioSciences Presents New Clinical Data At CROI 2015 From Trial Of ZFP Therapeutic Designed To Provide Functional Control Of HIV
2/26/2015
-
Pfizer's Meningitis B Vaccine Meets Safety, Tolerability Goals in Mid-Stage Study
2/25/2015
-
MicuRx Pharmaceuticals Initiates U.S. Phase 2 Clinical Trial For Novel Antibiotic MRX-I
2/25/2015
-
Dilafor Announces Positive Results From A Multi Dosing Safety And Pharmacokinetic Clinical Study
2/25/2015
-
Valeant Release: PROVENGE (sipuleucel-T) Demonstrates Sustained Immune Response Two Years After Treatment In Biochemically-Recurrent Prostate Cancer
2/25/2015
-
Celldex's Rindopepimut Deemed a Breakthrough By the FDA
2/24/2015
-
OncoGenex Pharmaceuticals Inc. And Sarah Cannon Research Institute Announce Completion Of Patient Enrollment In The Spruce Clinical Trial Evaluating Apatorsen In Combination With Carboplatin And Pemetrexed In Patients With Advanced Non-Squamous Non-Small
2/24/2015
-
Teva Pharmaceutical Industries Announces Positive Results For TEV-48125 In Phase IIb Chronic Migraine Study Meeting Primary And Secondary Endpoints
2/24/2015
-
Flexion Therapeutics Completes Enrollment In Pivotal Phase 2b Confirmatory Clinical Trial With Lead Compound FX006
2/24/2015
-
Neurotrope Announces Positive Top-Line Results From Its Phase 2a Study Of Bryostatin-1 In Alzheimer's Disease
2/24/2015
-
Galectin Therapeutics Announces Details Of The Design Of Its Phase 2 Program With GR-MD-02
2/24/2015
-
Progenics Pharmaceuticals, Inc. To Present Full Phase 2 Data For PSMA ADC At The 2015 American Society of Clinical Oncology GU Symposium
2/24/2015
-
Shares Surge as Novo Nordisk A/S Shows Off Positive Trial Data for Oral Insulin
2/23/2015
-
Celldex's Rindopepimut (Rintega) Receives FDA Breakthrough Therapy Designation For The Treatment Of Adult Patients With Egfrviii-Positive Glioblastoma
2/23/2015
-
NovoCure Ltd. Enrolls The First Patient In Its Phase II STELLAR Trial Of Tumor Treating Fields Together With Pemetrexed And Cisplatin Or Carboplatin For The Treatment Of Malignant Mesothelioma
2/23/2015
-
Results from AbbVie's Study Of VIEKIRA PAK (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) In Chronic Hepatitis C Patients With HIV-1 Co-Infection (TURQUOISE-I) Published Online In JAMA; Sub-Analyses To Be Presented At The Annual Conferen
2/23/2015